Atea Pharmaceuticals, Inc.
Industry: Life Sciences ・ $AVIR on Nasdaq
Insider Sale
+$219,104
-0.93%
Shares
Shares Volume: 56,910 Shares
Average Share Price: $3.85
INSIDER
Sommadossi Jean-Pierre
President, CEO, and Chairman (Director)
reported on Feb 2 2024
traded on Jan 31 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 6,041,557 |
| PURCHASES/SALES 1Y | 0 / 1 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $219,103.5 |
| INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 5 |
| PURCHASES/SALES 1Y | 0 / 5 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $85,442.46 |
| COMPANY PREVIOUS TRADES |